Slovenia starts using antibody treatment for Covid-19 patients
Ljubljana, 24 August - Slovenia has started using monoclonal antibody treatment for some patients with Covid-19, having received a shipment of 1,000 doses of the drug, which has been developed by the US biotech company Regeneron, as part of an EU contract.
The rest of this news item is available to subscribers.
The news item consists of 813 characters (without spaces) or 143 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.